分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Kaempferol promotes BMSC osteogenic differentiation and improves osteoporosis by downregulating miR-10a-3p and upregulating CXCL12

Hao Liu, Xin Yi, ShuTing Tu, Chong Cheng, Jun Luo

Journal:MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF:3.87

DOI:10.1016/j.mce.2020.111074

PMID:33157164

Published:2020-11-03

research field:分子生物学药理学干细胞研究骨科

Abstract

Background Kaempferol has improved the functions of various human diseases . Here, we aimed to probe into the potential molecular mechanism of Kaempferol to ameliorate osteoporosis . Methods Micro-computed tomography scanning was applied to assess the bone density of osteoporosis rats induced by ovariectomized. Quantitative real-time PCR was applied to detect the expressions of RUNX2 , Osterix, CXCL12, and miR-10a-3p. Western blot , Alizarin red staining, Alkaline Phosphatase Diethanolamine Activity Kit were applied to confirm the in vitro functions of Kaempferol. RNA Immunoprecipitation and dual-luciferase reporter gene experiments were applied to study the potential mechanism. Results The treatment of Kaempferol raised bone density in osteoporosis rats induced by ovariectomized, and boosted the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs), and raised the expressions of RUNX2, Osterix, and CXCL12, and lessened miR-10a-3p. From the potential mechanism analysis, we corroborated that miR-10a-3p and CXCL12 bound to each other, and Kaempferol boosted BMSC osteogenic differentiation and ameliorated osteoporosis by lessening miR-10a-3p and raising CXCL12. Conclusion Our data expounded that Kaempferol boosted BMSC osteogenic differentiation and ameliorated osteoporosis by lessening miR-10a-3p and raising CXCL12.

本文使用的Yeasen产品

购物车
客服
转染试用